A Rare e14a3 (b3a3) BCR-ABL Fusion Transcript in Chronic Myeloid Leukemia
- 1 July 2009
- journal article
- case report
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 11 (4) , 359-363
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A variant transcript, e1a3, of the minor BCR–ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literatureInternational Journal of Hematology, 2008
- Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing resultsBlood, 2006
- BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be presentCancer Genetics and Cytogenetics, 2005
- Characterization of the Different BCR-ABL Transcripts with a Single Multiplex RT-PCRThe Journal of Molecular Diagnostics, 2004
- Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR‐ABL transcript having a DNA breakpoint between ABL exons a2 and a3American Journal of Hematology, 2003
- Cytogenetic and Molecular Genetic Aspects of Chronic Myeloid LeukaemiaActa Haematologica, 2002
- CML with an e1a3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfallBlood, 2002
- Are aberrant BCR-ABL transcripts more common than previously thought?British Journal of Haematology, 2000
- Sequence and Analysis of the Human ABL Gene, the BCR Gene, and Regions Involved in the Philadelphia Chromosomal TranslocationGenomics, 1995
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990